Long-Term Follow-Up Confirms a Sustained Reduction in Deaths from Prostate Cancer with PSA Screening By Ogkologos - November 4, 2025 131 0 Facebook Twitter Google+ Pinterest WhatsApp Findings from the ERSPC study Source RELATED ARTICLESMORE FROM AUTHOR A Combination of Savolitinib and Osimertinib Prolongs PFS in Patients with EGFR-mutated NSCLC and Acquired MET Amplification After Progression On a First-Line EGFR TKI EMA Recommends Granting a Conditional Marketing Authorisation for Nogapendekin alfa Inbakicept Patient Guide in Testicular Cancer Now Available Also in German MOST POPULAR Child With Cancer Becomes Honorary First Responder July 15, 2019 Does Living Near Power Lines Increase My Risk of Cancer? March 17, 2022 Imiquimod is a Safe and Effective Alternative to Surgery for Vulvar... May 5, 2022 Coffee Shop Owner Runs Competitor’s Business For Free After Hearing He... December 18, 2019 Load more HOT NEWS Measurable Residual Disease Adapted Consolidation Strategy After Quadruplet Induction Therapy for... 4,000 Cancer Patients Affected by Diluted Chemotherapy Doses from Crooked Pharmacist A Cancer Revolution comes to Manchester: Patrick’s review Nivolumab Plus AVD Prolongs PFS in Adolescents and Adults with Advanced-Stage...
